(Q35976111)

11 August 2017

Effective treatment of malignant hypercalcaemia with a single intravenous infusion of clodronate (English)

1 reference

11 August 2017

O'Rourke NP

1

1 reference

11 August 2017

McCloskey EV

2

1 reference

11 August 2017

Vasikaran S

3

1 reference

11 August 2017

Eyres K

4

1 reference

11 August 2017

Fern D

5

1 reference

11 August 2017

Kanis JA

6

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 March 1993

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

67

1 reference

11 August 2017

3

1 reference

11 August 2017

560-563

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1993.102

11 August 2017

0 references

cites work

The hypercalcemia of cancer. Clinical implications and pathogenic mechanisms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968276

Mechanism of malignant hypercalcaemia in carcinoma of the breast

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968276

3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968276

Effects of a synthetic peptide of a parathyroid hormone-related protein on calcium homeostasis, renal tubular calcium reabsorption, and bone metabolism in vivo and in vitro in rodents

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968276

Effective short term treatment of Paget's disease with oral etidronate

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968276

Humoral hypercalcemia of malignancy: involvement of a novel hormone

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968276

Pathophysiological aspects and therapeutic approaches of tumoral osteolysis and hypercalcemia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968276

Treatment of hypercalcaemia of malignancy with clodronate

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968276

Treatment of bone metastases from breast cancer and myeloma with pamidronate.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968276

Bone and renal components in hypercalcemia of malignancy and responses to a single infusion of clodronate.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968276

Treatment of the hypercalcaemia of malignancy with intravenous clodronate.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968276

Treatment of hypercalcemia of malignancy with intravenous etidronate. A controlled, multicenter study. The Hypercalcemia Study Group

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968276

Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968276

24 September 2018

Measuring serum calcium.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968276

Treatment of tumor hypercalcemia with clodronate.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968276

Comparison of three intravenous bisphosphonates in cancer-associated hypercalcaemia

24 September 2018

1 reference

12 December 2020

Use of diphosphonates in hypercalcaemia due to malignancy

1 reference

12 December 2020

Diphosphonates in Paget's disease

1 reference

12 December 2020

Effects of intravenous etidronate disodium on skeletal and calcium metabolism

1 reference

12 December 2020

Reduced morbidity from skeletal metastases in breast cancer patients during long-term bisphosphonate (APD) treatment

1 reference

12 December 2020

Side-effects of pamidronate

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1993.102

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

8439504

1 reference